RFC4 is frequently overexpressed in colorectal cancer (CRC), and RFC4 overexpression is associated with tumor progression and shorter patient survival, possibly due to RFC4-mediated cell cycle arrest and the regulation of CRC cell proliferation [74]. This evidence concerns the gene RFC4 and colorectal carcinoma.